Regional axonal loss in the corpus callosum correlates with cerebral white matter lesion volume and distribution in multiple sclerosis

Brain

Volumn 123, Issue 9, 2000, Pages 1845-1849

  Evangelou, N ^a,b   Konz, D ^b   Esiri, M M ^b   Smith, S ^a,b   Palace, J ^b   Matthews, P M ^a,b  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Axon; Corpus callosum; Multiple sclerosis; Neuropathology; Wallerian degeneration

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORPUS CALLOSUM; DEMYELINATING DISEASE; HUMAN; HUMAN TISSUE; MULTIPLE SCLEROSIS; NERVE FIBER DEGENERATION; NEUROPATHOLOGY; PRIORITY JOURNAL; WHITE MATTER;

EID: 0033849266     PISSN: 00068950     EISSN: None     Source Type: Journal    
DOI: 10.1093/brain/123.9.1845     Document Type: Article

References (20)

1. Fiber composition of the human corpus callosum
2. Proton magnetic resonance spectroscopy of human brain in vivo in the evaluation of multiple sclerosis: Assessment of the load of disease
3. Cerebral infarctions: Evaluation with single-axis versus trace diffusion-weighted MR imaging
4. Topography of the human corpus callosum
5. Axonal damage correlates with disability in patients with relapsing-remitting multiple sclerosis: Results of a longitudinal magnetic resonance spectroscopy study
6. In vivo evidence for axonal dysfunction remote from focal cerebral demyelination of the type seen in multiple sclerosis
7. Quantitative pathological evidence for axonal loss in normal appearing white matter in multiple sclerosis
8. Axonal damage in acute multiple sclerosis lesions
9. Imaging axonal damage of normal-appearing white matter in multiple sclerosis
10. Spinal cord axonal loss in multiple sclerosis: A post mortem study
11. Observations on the histopathology of the cerebral lesions in disseminated sclerosis
12. Three-dimensional anisotropy contrast (3DAC) magnetic resonance imaging of the human brain: Application to assess Wallerian degeneration
13. Putting magnetic resonance spectroscopy studies in context: Axonal damage and disability in multiple sclerosis
14. Imaging of axonal damage in multiple sclerosis: Spatial distribution of magnetic resonance imaging lesions
15. Early, evolving Wallerian degeneration of the pyramidal tract in cerebrovascular diseases: MR study
16. The topography of commissural fibers
17. Cytokines and the nervous system, II: Actions and mechanisms of action
18. Neurotrophic molecules: Strategies for designing effective therapeutic molecules in neurodegeneration
19. Axonal transection in the lesions of multiple sclerosis